Literature DB >> 15520429

The meaning of the U.S. Preventive Services Task Force grade I recommendation: screening for hepatitis C virus infection.

Ned Calonge1, Gurvaneet Randhawa.   

Abstract

The U.S. Preventive Services Task Force (USPSTF) formulates evidence-based recommendations for clinical preventive services. These recommendations are communicated by letter grades that reflect the quality of evidence and the magnitude of net health benefit expected from delivering the preventive service. When the USPSTF finds insufficient evidence to determine the balance of health benefits or harms of delivering a preventive service, because of a lack of studies, poor-quality studies, or good-quality studies with conflicting results, the USPSTF assigns the service an I letter grade. The USPSTF found insufficient evidence to recommend for or against screening for hepatitis C virus infection in high-risk individuals (I letter grade). This recommendation reflects the need for further research that would provide adequate evidence to assess the net health benefit for persons screened for hepatitis C virus infection.

Entities:  

Mesh:

Year:  2004        PMID: 15520429     DOI: 10.7326/0003-4819-141-9-200411020-00014

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  5 in total

Review 1.  Hepatitis C: a review for primary care physicians.

Authors:  Tom Wong; Samuel S Lee
Journal:  CMAJ       Date:  2006-02-28       Impact factor: 8.262

2.  Hepatitis C screening: getting it right.

Authors:  Brian R Edlin
Journal:  Hepatology       Date:  2012-12-24       Impact factor: 17.425

3.  Context of clinical care: the case of hepatitis C in underserved communities--a report from the Primary Care Multiethnic Network (PRIME Net) Consortium.

Authors:  Robert R Leverence; Robert L Williams; Wilson Pace; Bennett Parnes; Yvonne Fry-Johnson; Dorothy R Pathak; Betty Skipper; Elvan Daniels; Philip Kroth
Journal:  J Am Board Fam Med       Date:  2009 Nov-Dec       Impact factor: 2.657

Review 4.  Molecular and contextual markers of hepatitis C virus and drug abuse.

Authors:  Paul Shapshak; Charurut Somboonwit; Lydia N Drumright; Simon D W Frost; Deborah Commins; Timothy L Tellinghuisen; William K Scott; Robert Duncan; Clyde McCoy; J Bryan Page; Brian Giunta; Francisco Fernandez; Elyse Singer; Andrew Levine; Alireza Minagar; Oluwadayo Oluwadara; Taiwo Kotila; Francesco Chiappelli; John T Sinnott
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

5.  Developing clinical practice guidelines: types of evidence and outcomes; values and economics, synthesis, grading, and presentation and deriving recommendations.

Authors:  Steven Woolf; Holger J Schünemann; Martin P Eccles; Jeremy M Grimshaw; Paul Shekelle
Journal:  Implement Sci       Date:  2012-07-04       Impact factor: 7.327

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.